Trial intelligence / Profile preview

Medidur FA in Geographic Atrophy

NCT00695318Phase 2Terminated

Sponsor
Alimera Sciences
Start
Dec 2008
Primary completion
Oct 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of fluocinolone in geographic atrophy (GA), sponsored by Alimera Sciences. Started Dec 2008; status: terminated.

02

Drugs

fluocinolone
03

Conditions

geographic atrophy (GA)

Beyond the preview

Go deeper on NCT00695318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00695318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call